Overcoming a Solid Solution System on Chiral Resolution: Combining Thermodynamics of Crystallization and Kinetics of Enantioselective Dissolution

14 February 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We have successfully performed chiral resolution of a key synthetic intermediate of ozanimod, rac-4-cyano-1-aminoindane, by combining crystallization and enantioselective dissolution. 4-Cyano-1-aminoindane forms a diastereomeric salt with di-p-toluoyl-L-tartaric acid, however the single crystallization gave moderate enantiomeric excess, which indicated the formation of solid solution. The formation of solid solution is typical trouble in chiral resolution, and the limitation of enrichment by the crystallization was indicated by the construction of binary and ternary phase diagrams. Thorough phase diagram study revealed the solid-state landscape of the diastereomeric salt and determined the condition for chiral resolution. Additionally, further enrichment was achieved by following enantioselective dissolution using the difference in dissolution rates of the diastereomeric pairs. This combination of crystallization and dissolution demonstrated chiral resolution of 4-cyano-1-aminoindane up to 96%, and proposed a new solution to the solid solution formation which is typical trouble of chiral resolution for the first time.

Keywords

chiral resolution
solid solution
salt formation
phase diagram
crystal engineering

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
General remarks, experimental data of HPLC analysis, DSC measurements, theoretical calculation, and chiral resolution.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.